APA

Weiner D. M., Burstein E. S., Nash N., Croston G. E., Currier E. A., Vanover K. E., Harvey S. C., Donohue E., Hansen H. C., Andersson C. M., Spalding T. A., Gibson D. F., Krebs-Thomson K., Powell S. B., Geyer M. A., Hacksell U. & Brann M. R. (20011018). 5-hydroxytryptamine2A receptor inverse agonists as antipsychotics. : The Journal of pharmacology and experimental therapeutics.

Chicago

Weiner D M, Burstein E S, Nash N, Croston G E, Currier E A, Vanover K E, Harvey S C, Donohue E, Hansen H C, Andersson C M, Spalding T A, Gibson D F, Krebs-Thomson K, Powell S B, Geyer M A, Hacksell U and Brann M R. 20011018. 5-hydroxytryptamine2A receptor inverse agonists as antipsychotics. : The Journal of pharmacology and experimental therapeutics.

Harvard

Weiner D. M., Burstein E. S., Nash N., Croston G. E., Currier E. A., Vanover K. E., Harvey S. C., Donohue E., Hansen H. C., Andersson C. M., Spalding T. A., Gibson D. F., Krebs-Thomson K., Powell S. B., Geyer M. A., Hacksell U. and Brann M. R. (20011018). 5-hydroxytryptamine2A receptor inverse agonists as antipsychotics. : The Journal of pharmacology and experimental therapeutics.

MLA

Weiner D M, Burstein E S, Nash N, Croston G E, Currier E A, Vanover K E, Harvey S C, Donohue E, Hansen H C, Andersson C M, Spalding T A, Gibson D F, Krebs-Thomson K, Powell S B, Geyer M A, Hacksell U and Brann M R. 5-hydroxytryptamine2A receptor inverse agonists as antipsychotics. : The Journal of pharmacology and experimental therapeutics. 20011018.